240 related articles for article (PubMed ID: 35428435)
1. Medical Treatment of Female Sexual Dysfunction.
Nappi RE; Tiranini L; Martini E; Bosoni D; Righi A; Cucinella L
Urol Clin North Am; 2022 May; 49(2):299-307. PubMed ID: 35428435
[TBL] [Abstract][Full Text] [Related]
2. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
[TBL] [Abstract][Full Text] [Related]
3. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
Kingsberg SA; Simon JA
J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
[TBL] [Abstract][Full Text] [Related]
4. Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women
Wåhlin-Jacobsen S; Kristensen E; Pedersen AT; Laessøe NC; Cohen AS; Hougaard DM; Lundqvist M; Giraldi A
J Sex Med; 2017 Mar; 14(3):366-379. PubMed ID: 28117267
[TBL] [Abstract][Full Text] [Related]
5. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic therapeutic options for sexual dysfunction.
Burton CS; Mishra K
Curr Opin Obstet Gynecol; 2022 Dec; 34(6):402-408. PubMed ID: 36036468
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for Sexual Dysfunction in Women.
Lee JH; Lee JE; Harsh V; Clayton AH
Curr Psychiatry Rep; 2022 Feb; 24(2):99-109. PubMed ID: 35102537
[TBL] [Abstract][Full Text] [Related]
8. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
Anderson R; Moffatt CE
J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
[TBL] [Abstract][Full Text] [Related]
9. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
10. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women.
Barakeh D; Mdaihly H; Karaoui LR
Ann Pharmacother; 2024 May; ():10600280241253273. PubMed ID: 38767282
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder-a claims database analysis.
Agrawal P; Lee YS; Grutman AJ; Dumas K; Kohn T; Kohn J; Yee AM; Clifton M
J Sex Med; 2024 Mar; 21(4):288-293. PubMed ID: 38441520
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?
Nappi RE; Tiranini L; Cucinella L; Martini E; Bosoni D; Righi A; Cassani C; Gardella B
Expert Opin Pharmacother; 2023 Jan; 24(1):135-143. PubMed ID: 35430926
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
15. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
16. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M; Rahman F; Puri LI; Rubin RS
Int J Impot Res; 2022 Nov; 34(7):635-641. PubMed ID: 36198811
[TBL] [Abstract][Full Text] [Related]
17. What Women Want? The State of the Art regarding the Treatment of Young Women with Hypoactive Sexual Desire Disorder.
de Oliveira L; Vignozzi L; Giraldi A; Varod S; Corona G; Reisman Y
Pharmacology; 2024; 109(2):69-75. PubMed ID: 38151009
[TBL] [Abstract][Full Text] [Related]
18. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Clayton AH; Dennerstein L; Pyke R; Sand M
Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
[TBL] [Abstract][Full Text] [Related]
19. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Sex Med; 2021 May; 18(5):849-867. PubMed ID: 33814355
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
